Skip to content

Clinical trials

Phase 1/2 Biliary Tract Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20141
20171
20191
20203
20211
20225
20234
20245
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Completed6
Active, not recruiting5
Terminated5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
National Cancer Institute (NCI)2
University of Michigan Rogel Cancer Center2
Amgen1
Avenzo Therapeutics, Inc.1
Basilea Pharmaceutica1
BioNTech SE1
Bolt Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms29
Carcinoma, Non-Small-Cell Lung11
Colorectal Neoplasms11
Endometrial Neoplasms10
Stomach Neoplasms10
Cholangiocarcinoma8
Ovarian Neoplasms7
Breast Neoplasms6
Pancreatic Neoplasms6
Esophageal Neoplasms5

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.